{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:48:29Z","timestamp":1770274109004,"version":"3.49.0"},"reference-count":10,"publisher":"Wiley","issue":"5-6","license":[{"start":{"date-parts":[[2005,4,22]],"date-time":"2005-04-22T00:00:00Z","timestamp":1114128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Pharma Physio"],"published-print":{"date-parts":[[2005,5]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>1.\u2002In developed countries, the major burden of disease is due to chronic diseases, such as heart disease and stroke. In contrast, the major burden of disease among people in developing countries has been due largely to diseases caused by malnutrition, poor sanitation and infection. In recent years, with increasing economic and demographic development, there has been a shift in developing countries from diseases caused by poverty towards chronic, non\u2010communicable, lifestyle\u2010related diseases. The rapid emergence of these chronic diseases has not occurred with a similarly rapid decline in infectious diseases. Therefore, these developing countries are experiencing high rates of both infectious and chronic diseases.<\/jats:p><jats:p>2.\u2002The increase in chronic diseases in developing countries has been brought about by the increasing prevalence of risk factors, such as increased alcohol consumption, smoking, obesity, physical inactivity and low fruit and vegetable intake. In parallel with this, there is also increased evidence of high blood pressure and high cholesterol levels.<\/jats:p><jats:p>3.\u2002The preventive strategies required to reverse this trend for these emerging diseases include the education of public health professionals, the introduction of surveillance activities to monitor changes in risk factors, the introduction of health promotion, the development of prevention research and improved advocacy for disease prevention programmes. Experience from other countries provides evidence that prevention programmes can work. The global challenge is to ensure that implementation of such programmes in the world's developing nations does not come too late.<\/jats:p>","DOI":"10.1111\/j.1440-1681.2005.04199.x","type":"journal-article","created":{"date-parts":[[2005,4,22]],"date-time":"2005-04-22T09:35:19Z","timestamp":1114162519000},"page":"374-376","source":"Crossref","is-referenced-by-count":23,"title":["HYPERTENSION 2020: CONFRONTING TOMORROW'S PROBLEM TODAY"],"prefix":"10.1111","volume":"32","author":[{"given":"Christopher M","family":"Reid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda G","family":"Thrift","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,4,22]]},"reference":[{"key":"e_1_2_3_2_2","doi-asserted-by":"publisher","DOI":"10.2307\/3349375"},{"key":"e_1_2_3_3_2","volume-title":"The World Heath Report 2002: Reducing Risks, Promoting Healthy Life.","author":"World Health Organization.","year":"2002"},{"key":"e_1_2_3_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.21.2616"},{"key":"e_1_2_3_5_2","first-page":"151","article-title":"1999 WHO\u2013ISH hypertension guidelines for the management of hypertension","volume":"17","author":"Guidelines Subcommittee.","year":"1999","journal-title":"J. Hypertens."},{"key":"e_1_2_3_6_2","volume-title":"The Global Burden of Disease.","author":"Murray C","year":"1996"},{"key":"e_1_2_3_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.18.1876"},{"key":"e_1_2_3_8_2","volume-title":"STEPS Program.","author":"World Health Organization.","year":"2002"},{"key":"e_1_2_3_9_2","volume-title":"A Public Health Action Plan to Prevent Heart Disease and Stroke.","author":"US Department of Health and Human Services.","year":"2003"},{"key":"e_1_2_3_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7404.1419"},{"key":"e_1_2_3_11_2","first-page":"33","article-title":"The North Karelia project: Nearly 20 years of successful prevention of CVD in Finland","volume":"11","author":"Puska P","year":"1992","journal-title":"Hygiene"}],"container-title":["Clinical and Experimental Pharmacology and Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1681.2005.04199.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1681.2005.04199.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T09:00:03Z","timestamp":1693386003000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1681.2005.04199.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,22]]},"references-count":10,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["10.1111\/j.1440-1681.2005.04199.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1681.2005.04199.x","archive":["Portico"],"relation":{},"ISSN":["0305-1870","1440-1681"],"issn-type":[{"value":"0305-1870","type":"print"},{"value":"1440-1681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,22]]}}}